Search

Xiaolan Zhou Phones & Addresses

  • 18582 Paseo Pizarro, Irvine, CA 92603
  • Fremont, CA
  • East Lansing, MI
  • Fort Wayne, IN
  • Lansing, MI

Work

Company: Svotek - Fremont, CA 2013 Position: Coating engineer

Education

School / High School: Tulane University- New Orleans, LA 2012 Specialities: Ph.D. in Physics

Resumes

Resumes

Xiaolan Zhou Photo 1

Xiaolan Zhou

View page
Xiaolan Zhou Photo 2

Xiaolan Zhou

View page
Xiaolan Zhou Photo 3

Xiaolan Zhou San Jose, CA

View page
Work:
SVOTek
Fremont, CA
2013 to 2014
Coating Engineer

Heliconix
Fremont, CA
2012 to 2013
Thin Film Engineer Intern

Department of Physics and Engineering Physics
New Orleans, LA
2006 to 2012
Research Assistant

National Laboratory for Infrared Physics

2004 to 2006
Researcher

Department of Physics

1998 to 2006
Assistant Professor

Education:
Tulane University
New Orleans, LA
2012
Ph.D. in Physics

Hunan University
Changsha, CN
M.S. in Physics department

Hunan Normal University
Changsha, CN
B.S. in Physics department

Publications

Us Patents

Administration Of An Anti-Activin-A Compound To A Subject

View page
US Patent:
20200108085, Apr 9, 2020
Filed:
Dec 13, 2019
Appl. No.:
16/714407
Inventors:
- Thousand Oaks CA, US
- South San Francisco CA, US
Isaac CIECHANOVER - Burlingame CA, US
Xiaolan ZHOU - Newbury Park CA, US
John Zhao-Nian LU - Alhambra CA, US
International Classification:
A61K 31/704
A61K 45/06
A61K 31/7068
C07K 16/22
A61K 38/17
A61K 39/395
Abstract:
The present invention relates to methods of treating ovarian cancer in a subject by administering to the subject by evaluating the subject's expression levels of specific biomarkers or angiogenic an anti-activin-A compound, such as an anti-activin-A antibody or an activin-A-binding receptor. In some embodiments, at least two compounds are administered to the subject, where the first compound is an anti-activin A compound, and the second compound is a chemotherapeutic compound, for example capecitabine. The invention further relates to methods of identifying subjects for treatment factors.

Administration Of An Anti-Activin-A Compound To A Subject

View page
US Patent:
20150359850, Dec 17, 2015
Filed:
Feb 3, 2014
Appl. No.:
14/764288
Inventors:
- South San Francisco CA, US
- Thousand Oaks CA, US
Isaac Ciechanover - Burlingame CA, US
Xiaolan Zhou - Newbury Park CA, US
John Zhao-Nian Lu - Culver City CA, US
Assignee:
SANTA MARIA BIOTHERAPEUTICS, INC. - South San Francisco CA
AMGEN INC. - Thousand Oaks CA
International Classification:
A61K 38/17
A61K 31/704
C07K 16/22
A61K 31/7068
A61K 45/06
A61K 39/395
Abstract:
The present invention relates to methods of treating ovarian cancer in a subject by administering to the subject by evaluating the subject's expression levels of specific biomarkers or angiogenic an anti-activin-A compound, such as an anti-activin-A antibody or an activin-A-binding receptor. In some embodiments, at least two compounds are administered to the subject, where the first compound is an anti-activin A compound, and the second compound is a chemotherapeutic compound, for example capecitabine. The invention further relates to methods of identifying subjects for treatment factors.
Xiaolan Zhou from Irvine, CA, age ~59 Get Report